Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Samuel R. Nussbaum Insider Profile
4 Followers
Samuel R. Nussbaum, EVP & Chief Medical Officer at Elevance Health, holds 47.52K shares in Biora Therapeutics (Ticker: BIOR), holds 97.69K shares in Motus Gi Holdings (Ticker: MOTS), holds 110.97K shares in Elevance Health (Ticker: ELV).
Samuel R. Nussbaum Elevance Health (ELV)EVP & Chief Medical Officer
Elevance Health (ELV)
EVP & Chief Medical Officer
Ranked #73,531 out of 98,909 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-17.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Samuel R. Nussbaum holds in companies
Most Profitable Insider Trade
The most profitable trade made by Samuel R. Nussbaum
Samuel R. Nussbaum's Trading History
Elevance Health
May 21, 2015
EVP & Chief Medical Officer
Uninformative Sell
1.65M
$59.33M
Motus Gi Holdings
Feb 19, 2021
Director
Uninformative Buy
―
$8.50K
Coherus Biosciences
―
Director
―
―
Biora Therapeutics
Jun 16, 2021
Director
Uninformative Buy
―
$35.02K
List of latest transactions for each holding click on a transaction to see Samuel R. Nussbaum's performance on stock
You May Also Like
Samuel R. Nussbaum insider profile FAQ
What is the percentage of profitable transactions made by Samuel R. Nussbaum?
The percentage of profitable transactions made by Samuel R. Nussbaum is 25%.
What is the average return per transaction made by Samuel R. Nussbaum?
The average return per transaction made by Samuel R. Nussbaum is -17.50%.
What stocks does Samuel R. Nussbaum hold?
Samuel R. Nussbaum holds: ELV, MOTS, CHRS, BIOR stocks.
What was Samuel R. Nussbaum’s latest transaction?
Samuel R. Nussbaum latest transaction was an Uninformative Buy of ―.
What was Samuel R. Nussbaum's most profitable transaction?
Samuel R. Nussbaum’s most profitable transaction was an Informative Buy of MOTS stock on February 21, 2018. The return on the trade was 1.80%.
What is Samuel R. Nussbaum's role in Elevance Health?
Samuel R. Nussbaum's role in Elevance Health is EVP & Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.